Logo

Bruker

JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, Bruker, 10x Genomics, More

Highlights from the first day included Exact Sciences' profitability forecast, an update on QuidelOrtho's integration, and Guardant Health's "quantum leap forward" with its "smart" liquid biopsy platform.

Bruker Takes Majority Stake in Proteomics Tech Firm Biognosys

With Bruker's investments, Biognosys said that it plans to open a US-based advanced proteomics contract research services lab.

Proteomics Research Innovation Progressed in 2022 Despite Challenging Business Conditions
Premium

For proteomics firms, 2022 marked a reversal from an earlier boom, but the field pushed into emerging areas like single-cell, single-molecule, and spatial analyses.

Precision Oncology Dx Firm Navignostics Raises CHF 7.5 M in Seed Funding From Bruker, Others

The company is developing a system combining single-cell spatial proteomic data with artificial intelligence analysis to guide therapy selection for cancer patients.

Bruker Posts 5 Percent Rise in Q3 Revenues

Revenues were $638.9 million in Q3, up from $608.9 million in Q3 2021 and beating the consensus Wall Street estimate of $608.2 million.

Oct 21, 2022

UBS Initiates Coverage of Bruker With Buy Rating

Sep 14, 2022

Thermo Fisher Releases New Tribrid Mass Spec as TOFs Cut Into Orbitraps' Dominance
Premium

Aug 12, 2022

In Brief This Week: Health Gene Technologies, IndyGeneUS AI, Natera, Proteintech Group, Bruker, More

Aug 4, 2022

Bruker's Q2 Revenues up 3 Percent as timsTOF Sales Top $125M Per Year
Premium

Jun 13, 2022

AGBT Showcases Diversity of Spatial Genomics Technologies
Premium

Jun 10, 2022

New Products Posted to GenomeWeb: Thermo Fisher, Bruker, Waters, Shimadzu, Newomics, Agilent, More

Jun 10, 2022

ASMS 2022 Sees Imaging Mass Spectrometry Take Center Stage
Premium

Jun 1, 2022

Max Planck Team Develops Workflow Combining Single-Cell Imaging With Deep Proteomic Profiling
Premium

Jun 1, 2022

Omics Tools and MDx Stocks Trade Flat in May, Largely Tracking Broader Market

May 20, 2022

In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More

May 4, 2022

Bruker Posts 7 Percent Rise in Q1 Revenues

Apr 22, 2022

New Products Posted to GenomeWeb: Bruker, Ares Genetics, Purigen, More

Apr 21, 2022

Spatial Proteomics Releases at AACR Offer Increases in Multiplexing, Throughput
Premium

Apr 19, 2022

Single-Cell Proteomics Throughput Gets Boost From Instrumentation, Informatics Improvements
Premium

Apr 11, 2022

AmberGen Receives Strategic Investment from Bruker

Apr 7, 2022

MALDI Clinical Microbiology Releases Bring New Features, Could Open Additional US Markets
Premium

Mar 15, 2022

Bruker Subsidiary Canopy Bio Targeting High-Throughput Spatial Proteomics With New Platform
Premium

Mar 15, 2022

PrognomiQ Closes $46M Financing Round

Mar 11, 2022

In Brief This Week: Labcorp, QuantuMDx, PerkinElmer, Bruker, Pathomics Health, More

Mar 2, 2022

Newomics, Bruker Ink Comarketing Deal for Mass Spec Drug Discovery Solutions

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.